首頁 > 市場調查報告書 > 製藥

藥物開發

市場調查報告書

商品編碼

1548173

全球藥物發現服務市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Drug Discovery Services Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年08月01日 | 出版商:

Value Market Research | 英文 222 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球藥物發現服務市場需求預計將從 2023 年的 251.5 億美元達到 2032 年近 863.4 億美元的市場規模，2024-2032 年研究期間複合年成長率為 14.69%。

藥物發現服務涉及識別和開發新藥物化合物的各種專門活動。這些服務包括目標識別、先導化合物最佳化、臨床前測試和早期臨床試驗。這些服務由合約研究組織 (CRO) 提供，這些組織提供藥物開發各個方面的專業知識，包括分子建模、高通量篩選和生物資訊學。這些服務旨在加速發現過程、降低成本並提高藥物開發成功的可能性。透過提供從初始研究到早期臨床階段的全面支持，這些服務在將新療法推向市場方面發揮著至關重要的作用。對創新藥物的需求不斷成長以及藥物開發過程日益複雜，推動了這些服務的市場。

市場動態

藥物發現服務市場是由藥物開發日益複雜性所推動的，這需要專門的服務來管理發現過程的各個階段。隨著製藥公司在開發新療法方面面臨越來越多的挑戰，他們越來越依賴藥物發現服務來提供專業知識、先進技術和簡化的流程，以提高效率和效果。技術進步為市場提供了重大機會。人工智慧和機器學習等創新能夠更快、更準確地識別潛在候選藥物，從而改變藥物發現。這些技術促進了預測建模、資料分析和虛擬篩選，顯著加快了發現過程並提高了成功率。

慢性病的流行和對新療法的需求推動了市場的成長。隨著癌症、心血管疾病和神經退化性疾病等疾病的全球負擔增加，對創新療法的需求不斷成長。藥物發現服務透過支持新療法和療法的開發，在滿足這一需求方面發揮著至關重要的作用。此外，將藥物發現活動外包給專業 CRO 的趨勢創造了更多機會。製藥公司尋求透過與提供專業知識和先進技術的 CRO 合作來降低成本並提高專注度。然而，這些服務的高成本和漫長的開發時間可能會阻礙市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球藥物發現服務市場的每個細分市場進行包容性評估。藥物發現服務業的成長和趨勢為這項研究提供了整體方法。

市場區隔

藥物發現服務市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按流程

目標選擇
目標驗證
命中線索識別
潛在客戶最佳化
候選人驗證

按類型

化學服務
生物服務

依藥物類型

小分子藥物
大分子藥物

按治療領域

糖尿病
神經病學
腫瘤學
傳染病
其他治療領域

按最終用戶

製藥與生物技術公司
合約研究組織
其他最終用戶

區域分析

本節涵蓋區域展望，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲藥物發現服務市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。藥物發現服務市場的主要參與者包括 Charles River Laboratories International Inc.、Thermo Fisher Scientific Inc.、Wuxi AppTec、Eurofins Scientific 等。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 按流程進行市場吸引力分析
- 按類型分類的市場吸引力分析
- 按藥物類型分類的市場吸引力分析
- 按治療領域分類的市場吸引力分析
- 最終用戶的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球藥物發現服務市場分析：依流程

按流程概述
按流程進行歷史和預測資料分析
目標選擇
目標驗證
命中線索識別
潛在客戶最佳化
候選人驗證

第 6 章：全球藥物發現服務市場分析：按類型

按類型概述
按類型分類的歷史和預測資料分析
化學服務
生物服務

第 7 章：全球藥物發現服務市場分析：按藥物類型

按藥物類型概述
按藥物類型的歷史和預測數據分析
小分子藥物
大分子藥物

第 8 章：全球藥物發現服務市場分析：依治療領域

按治療領域概述
按治療領域的歷史和預測數據分析
糖尿病
神經病學
腫瘤學
傳染病
其他治療領域

第 9 章：全球藥物發現服務市場分析：依最終使用者分類

最終用戶概述
最終用戶的歷史和預測數據分析
製藥與生物技術公司
合約研究組織
其他最終用戶

第 10 章：全球藥物發現服務市場分析：依地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 11 章：藥物發現服務公司的競爭格局

藥物發現服務市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 12 章：公司簡介

頂級公司市佔率分析
市場集中度
Charles River Laboratories International Inc.

公司概況
公司收入
產品
最新動態

Thermo Fisher Scientific Inc.

公司概況
公司收入
產品
最新動態

Wuxi AppTec

公司概況
公司收入
產品
最新動態

Eurofins Scientific

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112115522

The global demand for Drug Discovery Services Market is presumed to reach the market size of nearly USD 86.34 Billion by 2032 from USD 25.15 Billion in 2023 with a CAGR of 14.69% under the study period 2024-2032.

Drug discovery services involve various specialized activities to identify and develop new pharmaceutical compounds. These services include target identification, hit-to-lead optimization, preclinical testing, and early-phase clinical trials. These services are provided by contract research organizations (CROs), which offer expertise in various aspects of drug development, including molecular modeling, high-throughput screening, and bioinformatics. These services aim to accelerate the discovery process, reduce costs, and improve the likelihood of successful drug development. By providing comprehensive support from initial research through early clinical stages, these services play a crucial role in bringing new therapies to market. The increasing demand for innovative drugs and the growing complexity of drug development processes drive the market for these services.

MARKET DYNAMICS

The drug discovery services market is driven by the increasing complexity of drug development, which necessitates specialized services to manage various stages of the discovery process. As pharmaceutical companies face growing challenges in developing new therapies, they increasingly rely on drug discovery services to provide expertise, advanced technologies, and streamlined processes that enhance efficiency and effectiveness. Technological advancements offer significant opportunities within the market. Innovations such as artificial intelligence & machine learning are transforming drug discovery by enabling faster and more accurate identification of potential drug candidates. These technologies facilitate predictive modeling, data analysis, and virtual screening, significantly accelerating the discovery process and improving success rates.

The propelling prevalence of chronic diseases and the need for new treatments drive market growth. As the global burden of conditions such as cancer, cardiovascular diseases, and neurodegenerative disorders increases, there is a growing demand for innovative therapies. Drug discovery services play a crucial role in addressing this need by supporting the development of novel treatments and therapies. Additionally, the trend towards outsourcing drug discovery activities to specialized CROs creates further opportunities. Pharmaceutical companies seek to reduce costs and improve focus by partnering with CROs that offer specialized expertise and advanced technologies. However, the high cost of these services and the lengthy development timelines can hamper market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Drug Discovery Services. The growth and trends of Drug Discovery Services industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Drug Discovery Services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Process

Target Selection
Target Validation
Hit-to-Lead Identification
Lead Optimization
Candidate Validation

By Type

Chemistry Services
Biological Services

By Drug Type

Small-Molecule Drugs
Large-Molecule Drugs

By Therapeutic Area

Diabetes
Neurology
Oncology
Infectious Diseases
Other Therapeutic Areas

By End-user

Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Other End-users

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Drug Discovery Services market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Drug Discovery Services market include Charles River Laboratories International Inc., Thermo Fisher Scientific Inc., Wuxi AppTec, Eurofins Scientific, . This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. DRUG DISCOVERY SERVICES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Process
- 3.7.2 Market Attractiveness Analysis By Type
- 3.7.3 Market Attractiveness Analysis By Drug Type
- 3.7.4 Market Attractiveness Analysis By Therapeutic Area
- 3.7.5 Market Attractiveness Analysis By End-user
- 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL DRUG DISCOVERY SERVICES MARKET ANALYSIS BY PROCESS

5.1. Overview By Process
5.2. Historical and Forecast Data Analysis By Process
5.3. Target Selection Historic and Forecast Sales By Regions
5.4. Target Validation Historic and Forecast Sales By Regions
5.5. Hit-to-Lead Identification Historic and Forecast Sales By Regions
5.6. Lead Optimization Historic and Forecast Sales By Regions
5.7. Candidate Validation Historic and Forecast Sales By Regions

6. GLOBAL DRUG DISCOVERY SERVICES MARKET ANALYSIS BY TYPE

6.1. Overview By Type
6.2. Historical and Forecast Data Analysis By Type
6.3. Chemistry Services Historic and Forecast Sales By Regions
6.4. Biological Services Historic and Forecast Sales By Regions

7. GLOBAL DRUG DISCOVERY SERVICES MARKET ANALYSIS BY DRUG TYPE

7.1. Overview By Drug Type
7.2. Historical and Forecast Data Analysis By Drug Type
7.3. Small-Molecule Drugs Historic and Forecast Sales By Regions
7.4. Large-Molecule Drugs Historic and Forecast Sales By Regions

8. GLOBAL DRUG DISCOVERY SERVICES MARKET ANALYSIS BY THERAPEUTIC AREA

8.1. Overview By Therapeutic Area
8.2. Historical and Forecast Data Analysis By Therapeutic Area
8.3. Diabetes Historic and Forecast Sales By Regions
8.4. Neurology Historic and Forecast Sales By Regions
8.5. Oncology Historic and Forecast Sales By Regions
8.6. Infectious Diseases Historic and Forecast Sales By Regions
8.7. Other Therapeutic Areas Historic and Forecast Sales By Regions

9. GLOBAL DRUG DISCOVERY SERVICES MARKET ANALYSIS BY END-USER

9.1. Overview By End-user
9.2. Historical and Forecast Data Analysis By End-user
9.3. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
9.4. Contract Research Organizations Historic and Forecast Sales By Regions
9.5. Other End-users Historic and Forecast Sales By Regions

10. GLOBAL DRUG DISCOVERY SERVICES MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1 Overview, Historic and Forecast Data Sales Analysis
- 10.3.2 North America By Segment Sales Analysis
- 10.3.3 North America By Country Sales Analysis
- 10.3.4 United States Sales Analysis
- 10.3.5 Canada Sales Analysis
- 10.3.6 Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1 Overview, Historic and Forecast Data Sales Analysis
- 10.4.2 Europe By Segment Sales Analysis
- 10.4.3 Europe By Country Sales Analysis
- 10.4.4 United Kingdom Sales Analysis
- 10.4.5 France Sales Analysis
- 10.4.6 Germany Sales Analysis
- 10.4.7 Italy Sales Analysis
- 10.4.8 Russia Sales Analysis
- 10.4.9 Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1 Overview, Historic and Forecast Data Sales Analysis
- 10.5.2 Asia Pacific By Segment Sales Analysis
- 10.5.3 Asia Pacific By Country Sales Analysis
- 10.5.4 China Sales Analysis
- 10.5.5 India Sales Analysis
- 10.5.6 Japan Sales Analysis
- 10.5.7 South Korea Sales Analysis
- 10.5.8 Australia Sales Analysis
- 10.5.9 South East Asia Sales Analysis
- 10.5.10 Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1 Overview, Historic and Forecast Data Sales Analysis
- 10.6.2 Latin America By Segment Sales Analysis
- 10.6.3 Latin America By Country Sales Analysis
- 10.6.4 Brazil Sales Analysis
- 10.6.5 Argentina Sales Analysis
- 10.6.6 Peru Sales Analysis
- 10.6.7 Chile Sales Analysis
- 10.6.8 Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1 Overview, Historic and Forecast Data Sales Analysis
- 10.7.2 Middle East & Africa By Segment Sales Analysis
- 10.7.3 Middle East & Africa By Country Sales Analysis
- 10.7.4 Saudi Arabia Sales Analysis
- 10.7.5 UAE Sales Analysis
- 10.7.6 Israel Sales Analysis
- 10.7.7 South Africa Sales Analysis
- 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE DRUG DISCOVERY SERVICES COMPANIES

11.1. Drug Discovery Services Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12. COMPANY PROFILES OF DRUG DISCOVERY SERVICES INDUSTRY

12.1. Top Companies Market Share Analysis
12.2. Market Concentration Rate
12.3. Charles River Laboratories International Inc.
- 12.3.1 Company Overview
- 12.3.2 Company Revenue
- 12.3.3 Products
- 12.3.4 Recent Developments
12.4. Thermo Fisher Scientific Inc.
- 12.4.1 Company Overview
- 12.4.2 Company Revenue
- 12.4.3 Products
- 12.4.4 Recent Developments
12.5. Wuxi AppTec
- 12.5.1 Company Overview
- 12.5.2 Company Revenue
- 12.5.3 Products
- 12.5.4 Recent Developments
12.6. Eurofins Scientific
- 12.6.1 Company Overview
- 12.6.2 Company Revenue
- 12.6.3 Products
- 12.6.4 Recent Developments